Hong Kong Vaccine No-Show Rate Up After Side-Effect Reports
- More than 25% of those signed up failed to get shots Wednesday
- Concerns about side effects may be keeping some people away
This article is for subscribers only.
Fewer Hong Kong residents are showing up to get vaccines from Chinese maker Sinovac Biotech Ltd. amid reports of side effects, even as demand was strong for shots developed by Pfizer Inc.-BioNTech SE on the day of their debut.
The number of people who received their scheduled Sinovac immunizations at community vaccination centers fell to 72% on Wednesday, down from a high of more than 90% last week. More than one-third of those who signed up for the vaccine, 36%, were no-shows on Tuesday.